Bausch Health
BHC
219 hedge funds and large institutions have $1.56B invested in Bausch Health in 2025 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 65 reducing their positions, and 26 closing their positions.
35% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 26
3% more funds holding
Funds holding: 212 → 219 (+7)
1.56% less ownership
Funds ownership: 66.58% → 65.02% (-1.6%)
5% less capital invested
Capital invested by funds: $1.64B → $1.56B (-$86.1M)
11% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 65
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
63% less call options, than puts
Call options by funds: $15.4M | Put options by funds: $41.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Paulson & Co
New York
|
+$260M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$28.5M |
| 3 |
Goldman Sachs
New York
|
+$13.1M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$7.92M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Icahn Carl
Sunny Isles Beach,
Florida
|
-$231M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
-$39.6M |
| 3 |
MRCP
Maple Rock Capital Partners
Toronto,
Ontario, Canada
|
-$38.8M |
| 4 |
SG Americas Securities
New York
|
-$21.8M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$12.6M |
BHC Hedge Fund Activity: Q3 2025 in Review
219 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2025, worth a combined $1.56B — down 5.2% from $1.64B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new BHC positions and 26 closed out — a net gain of 9 holders — while 58 added to existing stakes and 65 trimmed.
The largest buyer was Paulson & Co, adding an estimated $260M. The largest seller was Icahn Carl, exiting entirely with an estimated $231M sold.
- 219 institutional investors held Bausch Health (BHC) as of Q3 2025, up from 212 in Q2 2025.
- Funds reported $1.56B of Bausch Health stock for Q3 2025, down 5.2% quarter-over-quarter.
- 35 funds opened new Bausch Health positions in Q3 2025 and 26 closed out, a net change of +9 holders.
- The largest Bausch Health buyer in Q3 2025 was Paulson & Co, an estimated $260M added.
- The largest Bausch Health seller in Q3 2025 was Icahn Carl, an estimated $231M sold.
Based on aggregated 13F filings for Q3 2025.